CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, reduction of CD34+ cells in chronic myelogenous leukemia (CML) xenograft model by EP4 receptor (prostaglandin receptor) agonist misoprostol or PGE1 (FDA-approved), suggests a context-dependent role of prostaglandins in stem-ness (174).